Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2013 (2013), Article ID 310427, 6 pages
http://dx.doi.org/10.1155/2013/310427
Review Article

Clinical Significance of AFP and PIVKA-II Responses for Monitoring Treatment Outcomes and Predicting Prognosis in Patients with Hepatocellular Carcinoma

Hana Park1,2 and Jun Yong Park3,4,5

1Department of Internal Medicine, CHA Bundang Medical Center, CHA University, Seongnam-si, Republic of Korea
2Institute of Gastroenterology, CHA Bundang Medical Center, CHA University, Seongnam-si, Republic of Korea
3Department of Internal Medicine, Yonsei University College of Medicine, 134 Sinchon-dong, Seodaemun-gu, Seoul, Republic of Korea
4Institute of Gastroenterology, Yonsei University College of Medicine, Seoul, Republic of Korea
5Yonsei Liver Cancer Special Clinic, Yonsei University College of Medicine, Seoul, Republic of Korea

Received 21 November 2013; Accepted 9 December 2013

Academic Editor: Mohammad Ahmad al-Shatouri

Copyright © 2013 Hana Park and Jun Yong Park. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Hana Park and Jun Yong Park, “Clinical Significance of AFP and PIVKA-II Responses for Monitoring Treatment Outcomes and Predicting Prognosis in Patients with Hepatocellular Carcinoma,” BioMed Research International, vol. 2013, Article ID 310427, 6 pages, 2013. doi:10.1155/2013/310427